A new experimental injection is drawing attention after researchers reported an average 12.01% reduction in visceral abdominal fat four weeks after treatment. Taiwan-based Caliway Biopharmaceuticals d…
A new experimental injection is drawing attention after researchers reported an average 12.01% reduction in visceral abdominal fat four weeks after treatment. Taiwan-based Caliway Biopharmaceuticals d…
